ACRO Executive Director, Doug Peddicord, authored an Op-Ed for Morning Consult on the spotlight put on clinical trials during the pandemic, and
what it means for the future of the industry.
ACRO’s Diversity & Inclusion Committee has released a statement of principles to guide the work that ACRO and its members are doing
to improve diversity and inclusion in clinical trials.
ACRO released a new analytical report on the takeaways from our 2020 landscape survey of RBM and RBQM implementation.
Click here for ACRO’s latest statements on the COVID-19 pandemic.
Read about ACRO’s initiatives, COVID-19 efforts, and more.
Take a look at how our members are innovating in top focus areas.
Drug repurposing can reduce time and cost, while also lowering risk, during drug development for cancers and rare illnesses. @IQVIA_global outlines the four main types of the practice, helpful data-driven approaches, and challenges. https://bit.ly/3PA4jjI
How can a #ClinicalTrial team best navigate medical, legal, and regulatory reviews? @veevasystems shares how building a foundation of support and teaching team members to become reviewers themselves can upgrade the process. https://bit.ly/3Fz7ELl
Despite improvements in gender representation in #ClinicalResearch, there remains significant work to be done to close the gap. @PPDCRO details what drug developers can do to increase participation for women, including enhancing flexibility. https://bit.ly/3PbhAyT
Get ACRO’s newsletter to stay informed about our work and the industry.
Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…
Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…
The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…
Today, ACRO released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now…
Washington, DC — The Association of Clinical Research Organizations (ACRO) congratulates Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) on the release…
Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial…
Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »
ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »
ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »
In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »
ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »
We help create a global regulatory and business environment
where ACRO members succeed
';